ADPT
ADPT
US00650F1093
Adaptive Biotechnologies Corpor
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 276.976.000 178.957.000
54.8%
Cost of Revenue 71.359.000 72.080.000
1.0%
Gross Profit 205.617.000 106.877.000
92.4%
262.740.000 262.221.000
0.2%
Operating Income -57.123.000 -155.344.000
63.2%
Pretax Income -59.457.000 -159.595.000
62.7%
Net Income Common Stockholders -59.499.000 -159.492.000
62.7%
-- --
--
-- --
--
ende